ZEVRA THERAPEUTICS, INC. Annual Share-based Payment Arrangement, Expense in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Zevra Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2013 to 2023.
  • Zevra Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $2.63M, a 139% increase year-over-year.
  • Zevra Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $9.01M, a 153% increase year-over-year.
  • Zevra Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $5.95M, a 38.7% increase from 2022.
  • Zevra Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $4.29M, a 76.3% increase from 2021.
  • Zevra Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $2.44M, a 2.21% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $5.95M +$1.66M +38.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-01
2022 $4.29M +$1.86M +76.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 $2.44M -$55K -2.21% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-07
2020 $2.49M -$1.92M -43.5% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 $4.41M -$2.09M -32.1% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-12
2018 $6.5M +$1.93M +42.4% Jan 1, 2018 Dec 31, 2018 10-K 2020-02-28
2017 $4.56M -$2.04M -30.9% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-01
2016 $6.6M +$4.23M +179% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-30
2015 $2.37M +$2.16M +1007% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-30
2014 $214K +$80K +59.7% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-10
2013 $134K Jan 1, 2013 Dec 31, 2013 10-K 2016-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.